Literature DB >> 23850168

The distinct role of T cell costimulation in antiviral immunity.

Suzanne P M Welten1, Cornelis J M Melief, Ramon Arens.   

Abstract

Defining the critical molecular interactions for inducing antiviral T cell responses is important for improvement of vaccines. Recent progress in understanding the role of T cell costimulatory molecules provides the insight that these molecules not only enhance CD4 and CD8 T cell responses in acute infections but also have an impact in latent and chronic viral infections. Intriguingly, the requirements for T cell costimulation seem to be distinct for each virus but nonetheless at least one or more costimulatory pathways are instrumental for development of protective immunity. Remarkably, certain viruses have evolved mechanisms to evade host costimulatory pathways to their advantage. These new insights have important implications for rational vaccine design.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23850168     DOI: 10.1016/j.coviro.2013.06.012

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  10 in total

1.  Expression of toll-like receptors and co-stimulatory molecules in lymphoid tissue during experimental infection of beef calves with bovine viral diarrhea virus of low and high virulence.

Authors:  Roberto A Palomares; Jacqueline Parrish; Amelia R Woolums; Kenny V Brock; David J Hurley
Journal:  Vet Res Commun       Date:  2014-08-23       Impact factor: 2.459

2.  Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.

Authors:  Peter D Krueger; Taeg S Kim; Sun-Sang J Sung; Thomas J Braciale; Young S Hahn
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

Review 3.  Peripheral regulation of T cells by dendritic cells during infection.

Authors:  Emily A Hemann; Kevin L Legge
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

4.  Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.

Authors:  Janet J Sei; Scott Haskett; Lauren W Kaminsky; Eugene Lin; Mary E Truckenmiller; Clifford J Bellone; R Mark Buller; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2015-06-24       Impact factor: 6.823

Review 5.  Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging.

Authors:  Joshua J Michel; Patricia Griffin; Abbe N Vallejo
Journal:  Front Immunol       Date:  2016-11-24       Impact factor: 7.561

Review 6.  Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.

Authors:  Eleni Panagioti; Paul Klenerman; Lian N Lee; Sjoerd H van der Burg; Ramon Arens
Journal:  Front Immunol       Date:  2018-02-16       Impact factor: 7.561

Review 7.  The hallmarks of CMV-specific CD8 T-cell differentiation.

Authors:  Sara P H van den Berg; Iris N Pardieck; Josien Lanfermeijer; Delphine Sauce; Paul Klenerman; Debbie van Baarle; Ramon Arens
Journal:  Med Microbiol Immunol       Date:  2019-04-13       Impact factor: 3.402

8.  The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion.

Authors:  Suzanne P M Welten; Anke Redeker; Kees L M C Franken; Jennifer D Oduro; Ferry Ossendorp; Luka Čičin-Šain; Cornelis J M Melief; Peter Aichele; Ramon Arens
Journal:  Elife       Date:  2015-08-11       Impact factor: 8.140

9.  CD8+ TCR transgenic strains expressing public versus private TCR targeting the respiratory syncytial virus K(d)M2(82-90) epitope demonstrate similar functional profiles.

Authors:  Erez Bar-Haim; Noam Erez; Allison M W Malloy; Barney S Graham; Tracy J Ruckwardt
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

10.  Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans.

Authors:  Sina Fellermeier-Kopf; Friederike Gieseke; Ugur Sahin; Dafne Müller; Klaus Pfizenmaier; Roland E Kontermann
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.